From Medscape Oncology

Coverage from the

American Association for Cancer Research (AACR) Annual Meeting 2022

April 08 - 13, 2022; New Orleans, LA and Virtual/Online

April 08 - 13, 2022 New Orleans, LA and Virtual/Online

AACR 2022 Preop Nivolumab Plus Chemo 'a Quantum Leap' in NSCLC Therapy Further data from the pivotal Checkmate 816 trial continue to support the combination of nivolumab with chemotherapy in the neoadjuvant setting for patients with resectable non–small cell lung cancer.
Medscape Medical News, April 12, 2022
AACR 2022 'Truly Impressive' Responses in Lymphoma With Novel Cell Therapy Activated natural killer cells combined with a bispecific antibody showed strong activity in heavily pretreated patients with lymphoma expressing the CD30 antigen.
Medscape Medical News, April 11, 2022

Conference News

AACR 2022 Novel COVID-19 Vaccine for Patients With Blood Cancers
Medscape Medical News, April 19, 2022
AACR 2022 New Cancer Diet Studies Confirm Effects of Veggies and Red Meat
Medscape Medical News, April 19, 2022
AACR 2022 Novel CAR T Therapy for Solid Tumors: 'Exciting Advance'
Medscape Medical News, April 18, 2022
AACR 2022 Biomarker Predicts Nonresponse to CAR T in Pediatric ALL
Medscape Medical News, April 18, 2022
AACR 2022 Assay-Guided Chemo in Recurrent Glioma Linked to Longer Survival
Medscape Medical News, April 18, 2022
AACR 2022 Genetically Adjusted PSA May Improve Prostate Cancer Screening
Medscape Medical News, April 14, 2022

AACR 2022 'Major Advance': Sotorasib Benefit Persists in KRAS+ NSCLC
Medscape Medical News, April 13, 2022
AACR 2022 Better Survival in Older Cancer Patients Who Also Take Metformin
Medscape Medical News, April 12, 2022
AACR 2022 Preop Nivolumab Plus Chemo 'a Quantum Leap' in NSCLC Therapy
Medscape Medical News, April 12, 2022
AACR 2022 More Drugs Tested in Pediatric Cancer: RACE for Children Act
Medscape Medical News, April 11, 2022
AACR 2022 'Truly Impressive' Responses in Lymphoma With Novel Cell Therapy
Medscape Medical News, April 11, 2022
AACR 2022 Recurrent DCIS Can Be Genetically Distinct From Primary Lesion
Medscape Medical News, April 11, 2022

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News from AACR 2021

Healthy Lifestyle May Offset Genetic Risk in Prostate Cancer Adhering to a healthy lifestyle may offset the heightened risk of lethal prostate cancer in patients with adverse genetic risk factors, according to results of a large US study presented at AACR 2021.
Medscape Medical News, Apr 15, 2021
Made-to-Order TILs Effective Against Metastatic Melanoma Cell therapy with tumor-infiltrating lymphocytes (TILs) extracted from tumor tissue yielded responses in patients with heavily pretreated malignant melanoma.
Medscape Medical News, Apr 15, 2021
Antibiotics May Prolong PFS in HCC Patients on Immunotherapy Taking antibiotics 30 days before or after starting an immune checkpoint inhibitor was associated with a benefit in progression-free survival (PFS) for patients with hepatocellular carcinoma.
Medscape Medical News, Apr 21, 2021

Previous Coverage